Submit your email to push it up the queue
NeoGenomics Laboratories, Inc., a leading provider of cancer-focused genetic testing services, is headquartered in the United States. Founded in 2001, the company has established itself as a key player in the oncology diagnostics industry, with major operational regions across North America and Europe. Specialising in a comprehensive range of services, including molecular testing, pathology, and clinical trial support, NeoGenomics is renowned for its innovative approach to cancer diagnostics. The company’s commitment to high-quality, accurate testing has positioned it as a trusted partner for healthcare providers and researchers alike. With numerous accolades and a robust market presence, NeoGenomics continues to advance the field of oncology through cutting-edge technology and a dedication to improving patient outcomes.
How does NeoGenomics Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
NeoGenomics Laboratories, Inc.'s score of 29 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NeoGenomics Laboratories, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary of NeoGenomics, Inc., any potential emissions data or climate commitments would be inherited from the parent organisation. However, no specific information regarding emissions or climate initiatives has been provided from this source either. In the context of the industry, it is essential for companies like NeoGenomics to establish clear climate commitments and reduction targets to align with global sustainability goals. Without such data, it is challenging to assess their environmental impact or commitment to reducing carbon emissions.
Access structured emissions data, company-specific emission factors, and source documents
2023 | |
---|---|
Scope 1 | 536,000 |
Scope 2 | 4,181,000 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NeoGenomics Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.